J. Douma
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Neutropenia and Cancer Infections
- Cancer survivorship and care
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 6
- Colorectal Cancer Treatments and Studies 4
- Cancer Treatment and Pharmacology 2
-
- Cancer Genomics and Diagnostics 1
- Breast Cancer Treatment Studies 1
- Co-authors
- Cornelis J.A. Punt (2 shared papers)Jaap Wals (2 shared papers)Ninja F. Antonini (2 shared papers)Frans Erdkamp (2 shared papers)Miriam Koopman (2 shared papers)Cees J. Rodenburg (2 shared papers)Robert S. de Jong (2 shared papers)Gerard Vreugdenhil (1 shared paper)
- Journals
- Annals of Oncology (2 papers)Nuclear Medicine Communications (1 paper)Journal of Clinical Oncology (1 paper)European Journal of Cancer (1 paper)European Journal of Cancer Supplements (1 paper)
- Partner nations
- NetherlandsCanadaDenmark
In The Last Decade
J. Douma
7 papers receiving 493 citations
Peers
Comparison fields: 5 of 41
- Oncology 404
- Cancer Research 186
- Dermatology 43
- Pulmonary and Respiratory Medicine 43
- Hematology 11
Countries citing papers authored by J. Douma
This map shows the geographic impact of J. Douma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Douma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Douma more than expected).
Fields of papers citing papers by J. Douma
This network shows the impact of papers produced by J. Douma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Douma. The network helps show where J. Douma may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Douma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 441 | |
| 2 | 2006 | 33 | |
| 3 | Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer. | 1997 | 29 |
| 4 | 2002 | 24 | |
| 5 | 1999 | 1 | |
| 6 | 2007 | 1 | |
| 7 | 2009 | 1 |
About J. Douma
J. Douma is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Genetics and Pulmonary and Respiratory Medicine, having authored 7 papers that have together received 530 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (2 papers), Genetic factors in colorectal cancer (2 papers), Cancer Genomics and Diagnostics (1 paper), Breast Cancer Treatment Studies (1 paper), Gastric Cancer Management and Outcomes (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Oncology (404 citations), Cancer Research (186 citations), Dermatology (43 citations), Pulmonary and Respiratory Medicine (43 citations) and Hematology (11 citations). J. Douma has collaborated with scholars based in Netherlands, Canada and Denmark. Frequent co-authors include Cornelis J.A. Punt, Jaap Wals, Ninja F. Antonini, Frans Erdkamp, Miriam Koopman, Cees J. Rodenburg, Robert S. de Jong, Gerard Vreugdenhil, A.H. Honkoop and Michael Murawsky. Their work appears in journals such as Annals of Oncology, Nuclear Medicine Communications, Journal of Clinical Oncology, European Journal of Cancer and European Journal of Cancer Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.